Nonlinear analysis of beat-to-beat variability of action potential time series data identifies dynamic re-entrant substrates in a hypokalaemic mouse model of acquired long QT syndrome

[1]  Ronald A. Li,et al.  Arrhythmic Risk Assessment of Hypokalaemia Using Human Pluripotent Stem Cell-Derived Cardiac Anisotropic Sheets , 2021, Frontiers in Cell and Developmental Biology.

[2]  Qingpeng Zhang,et al.  Measures of repolarization variability predict ventricular arrhythmogenesis in heptanol-treated Langendorff-perfused mouse hearts , 2021, Current research in physiology.

[3]  Henggui Zhang,et al.  Arrhythmogenic Mechanisms in Hypokalaemia: Insights From Pre-clinical Models , 2021, Frontiers in Cardiovascular Medicine.

[4]  P. Kirchhof,et al.  Effects of genetic background, sex, and age on murine atrial electrophysiology. , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  R. Walia,et al.  Seven day continuous ambulatory electrocardiographic telemetric study with pocket electrocardiographic recording device for detecting hydroxychloroquine induced arrhythmias , 2020, Journal of family medicine and primary care.

[6]  H. Huikuri,et al.  Increased Beat-to-Beat Variability of T-Wave Heterogeneity Measured From Standard 12-Lead Electrocardiogram Is Associated With Sudden Cardiac Death: A Case–Control Study , 2020, Frontiers in Physiology.

[7]  Tong Liu,et al.  Quantification of Beat-To-Beat Variability of Action Potential Durations in Langendorff-Perfused Mouse Hearts , 2018, Front. Physiol..

[8]  H. Ehmke,et al.  Genetic background dominates the susceptibility to ventricular arrhythmias in a murine model of β-adrenergic stimulation , 2018, Scientific Reports.

[9]  Ronald A. Li,et al.  Effects of pharmacological gap junction and sodium channel blockade on S1S2 restitution properties in Langendorff-perfused mouse hearts , 2017, Oncotarget.

[10]  A. Varró,et al.  Beat-to-beat variability of cardiac action potential duration: underlying mechanism and clinical implications. , 2017, Canadian journal of physiology and pharmacology.

[11]  B. Yan,et al.  Isolated heart models for studying cardiac electrophysiology: a historical perspective and recent advances , 2017, Journal of basic and clinical physiology and pharmacology.

[12]  Zhilin Qu,et al.  Electrophysiology of Hypokalemia and Hyperkalemia. , 2017, Circulation. Arrhythmia and electrophysiology.

[13]  G. Tse,et al.  Gap junction inhibition by heptanol increases ventricular arrhythmogenicity by reducing conduction velocity without affecting repolarization properties or myocardial refractoriness in Langendorff-perfused mouse hearts , 2016, Molecular medicine reports.

[14]  D. Thompson,et al.  Detailed analysis of the impact of age on the QT interval , 2016, Journal of geriatric cardiology : JGC.

[15]  G. Tse,et al.  Monophasic action potential recordings: which is the recording electrode? , 2016, Journal of basic and clinical physiology and pharmacology.

[16]  G. Tse,et al.  Restitution analysis of alternans using dynamic pacing and its comparison with S1S2 restitution in heptanol-treated, hypokalaemic Langendorff-perfused mouse hearts , 2016, Biomedical reports.

[17]  Yiyi Zhang,et al.  Entropy of cardiac repolarization predicts ventricular arrhythmias and mortality in patients receiving an implantable cardioverter-defibrillator for primary prevention of sudden death. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[18]  G. Tse,et al.  Atrial Anti-Arrhythmic Effects of Heptanol in Langendorff-Perfused Mouse Hearts , 2016, PloS one.

[19]  G. Tse,et al.  Ventricular anti-arrhythmic effects of heptanol in hypokalaemic, Langendorff-perfused mouse hearts , 2016, Biomedical reports.

[20]  Ralf L. M. Peeters,et al.  Determinants of Beat-to-Beat Variability of Repolarization Duration in the Canine Ventricular Myocyte: A Computational Analysis , 2013, PLoS Comput. Biol..

[21]  Mathias Meine,et al.  Beat-to-beat variability of repolarization as a new biomarker for proarrhythmia in vivo. , 2012, Heart rhythm.

[22]  Oleg E. Osadchii Effects of ventricular pacing protocol on electrical restitution assessments in guinea‐pig heart , 2012, Experimental physiology.

[23]  A. Grace,et al.  Ventricular arrhythmogenesis following slowed conduction in heptanol-treated, Langendorff-perfused mouse hearts , 2012, The Journal of Physiological Sciences.

[24]  Kevin Burrage,et al.  A multiscale investigation of repolarization variability and its role in cardiac arrhythmogenesis. , 2011, Biophysical journal.

[25]  O. Osadchii Mechanisms of hypokalemia‐induced ventricular arrhythmogenicity , 2010, Fundamental & clinical pharmacology.

[26]  H. Wichmann,et al.  Usefulness of short-term variability of QT intervals as a predictor for electrical remodeling and proarrhythmia in patients with nonischemic heart failure. , 2010, The American journal of cardiology.

[27]  L. Virág,et al.  Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations , 2010, Basic Research in Cardiology.

[28]  Antonio Zaza,et al.  Reverse rate dependency is an intrinsic property of canine cardiac preparations. , 2009, Cardiovascular research.

[29]  J. Couderc Cardiac regulation and electrocardiographic factors contributing to the measurement of repolarization variability. , 2009, Journal of electrocardiology.

[30]  H. Ibsen,et al.  Hypokalemia and ventricular arrhythmias in acute myocardial infarction. , 2009, Acta medica Scandinavica.

[31]  R. Solomon,et al.  Importance of potassium in patients with acute myocardial infarction. , 2009, Acta medica Scandinavica. Supplementum.

[32]  Massimiliano Zaniboni,et al.  Temporal variability of repolarization in rat ventricular myocytes paced with time‐varying frequencies , 2007, Experimental physiology.

[33]  Gavin D. Perkins,et al.  European Resuscitation Council Guidelines for Resuscitation 2005 , 2005 .

[34]  Milan Stengl,et al.  Increased Short-Term Variability of Repolarization Predicts d-Sotalol–Induced Torsades de Pointes in Dogs , 2004, Circulation.

[35]  W. Zareba,et al.  Temporal Complexity of Repolarization and Mortality in Patients with Implantable Cardioverter Defibrillators , 2003 .

[36]  A. Varró,et al.  Endocardial versus epicardial differences in L-type calcium current in canine ventricular myocytes studied by action potential voltage clamp. , 2003, Cardiovascular research.

[37]  A Rastergar,et al.  A Practical Guide for Medical Teachers. , 2002, Postgraduate medical journal.

[38]  M R Franz,et al.  Monophasic Action Potential Recordings from Intact Mouse Heart: Validation, Regional Heterogeneity, and Relation to Refractoriness , 2001, Journal of cardiovascular electrophysiology.

[39]  J. Nerbonne,et al.  Rapid ventricular repolarization in rodents: electrocardiographic manifestations, molecular mechanisms, and clinical insights. , 2000, Journal of electrocardiology.

[40]  M. Zaniboni,et al.  Beat-to-beat repolarization variability in ventricular myocytes and its suppression by electrical coupling. , 2000, American journal of physiology. Heart and circulatory physiology.

[41]  J. Bache European Resuscitation Council Guidelines for Resuscitation , 1998 .

[42]  B. Johansson,et al.  Malignant Arrhythmias in Acute Myocardial Infarction , 1984, Drugs.

[43]  J. Soar,et al.  Guidelines for Resuscitation 2005 Section 7 . Cardiac arrest in special circumstances , 2005 .

[44]  G. Breithardt,et al.  Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia , 2003, Basic Research in Cardiology.

[45]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[46]  B. Johansson,et al.  Malignant arrhythmias in acute myocardial infarction. Relationship to serum potassium and effect of selective and non-selective beta-blockade. , 1984, Drugs.